Hypertension, Pregnancy Induced
12
4
6
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
33%
4 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Treatment With Aspirin After Preeclampsia: TAP Trial
Optimal Blood Pressure Treatment Thresholds Postpartum
Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
Enhancing Care & Outcomes for Patients During the First Postpartum Year
Better Understanding Patient Perspectives of an Educational Tool for Postpartum Hypertensive Patients
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer
Blood Pressure Variability Effect on Right Ventricular Strain in Women With Hypertensive Disorders With Pregnancy
Community Level Interventions for Pre-eclampsia
Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy